Automated Self-Adjusting Subcutaneous Insulin Algorithm (SQIA) Improves Glycemic Control in Hospitalized Patients-Three-Year ExperienceDIABETESIF7.52024-06-140PRE
Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized PatientsJOURNAL OF DIABETES SCIENCE AND TECHNOLOGYIF3.72024-03-071PRE
Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors-Lessons From a Case Series and Strategies to Decrease IncidenceENDOCRINE PRACTICEIF4.62022-09-0130OAAI
Inpatient glycemic control and community-acquired pneumonia outcomes in the pre-COVID-19 era: reviewing the evidence to pave the road for future studiesBMJ OPEN DIABETES RESEARCH & CAREIF4.12022-07-050OAAI
Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetesBMJ OPEN DIABETES RESEARCH & CAREIF4.12021-05-3115OAAI
Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic KetoacidosisDIABETESIF7.52021-05-2113OA
A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's EducationJOURNAL OF DIABETES SCIENCE AND TECHNOLOGYIF3.72020-08-140OAAI
Standardized Assessment of Diabetes Distress in Routine Type 1 Diabetes CareDIABETESIF7.52020-06-010PRE
Metabolomic Profiling during Diabetic Ketoacidosis (DKA) Demonstrates Unique Defects Underlying the Pathophysiology of Ketosis-Prone DiabetesDIABETESIF7.52020-06-010PRE
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future PotentialsCURRENT DIABETES REPORTSIF6.42018-07-1111PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向